Concord Biotech Limited
CONCORDBIO
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 2026312
Quarter ₹ crore YoY Sept 2024 310 +18.2% Dec 2024 244 +1.4% Mar 2025 430 +34.8% Jun 2025 204 -5.5% Sept 2025 247 -20.4% Dec 2025 278 +13.9% Mar 2026 326 -24.2% Jun 2026 261 +27.7% Sept 2026 312 +26.4% - ₹ crore
Sept 202610
Quarter ₹ crore Sept 2024 10 Dec 2024 15 Mar 2025 9 Jun 2025 14 Sept 2025 13 Dec 2025 10 Mar 2026 16 Jun 2026 13 Sept 2026 10 - ₹ crore
Sept 2026323
Quarter ₹ crore Sept 2024 320 Dec 2024 259 Mar 2025 439 Jun 2025 218 Sept 2025 260 Dec 2025 288 Mar 2026 341 Jun 2026 274 Sept 2026 323 - Cost structure
- ₹ crore
Sept 202649
Quarter ₹ crore Sept 2024 34 Dec 2024 35 Mar 2025 39 Jun 2025 38 Sept 2025 43 Dec 2025 44 Mar 2026 45 Jun 2026 41 Sept 2026 49 - ₹ crore
Sept 2026221
Quarter ₹ crore Sept 2024 187 Dec 2024 160 Mar 2025 254 Jun 2025 160 Sept 2025 175 Dec 2025 195 Mar 2026 223 Jun 2026 191 Sept 2026 221 - Exceptional items and tax
- ₹ crore
Sept 2026102
Quarter ₹ crore Sept 2024 133 Dec 2024 99 Mar 2025 185 Jun 2025 57 Sept 2025 86 Dec 2025 90 Mar 2026 118 Jun 2026 82 Sept 2026 102 - ₹ crore
Sept 202626
Quarter ₹ crore Sept 2024 35 Dec 2024 25 Mar 2025 43 Jun 2025 15 Sept 2025 23 Dec 2025 23 Mar 2026 28 Jun 2026 21 Sept 2026 26 - Profit
- ₹ crore
Sept 202676
Quarter ₹ crore YoY Sept 2024 99 +16.8% Dec 2024 74 -0.6% Mar 2025 142 +46.0% Jun 2025 43 -26.9% Sept 2025 63 -36.3% Dec 2025 68 -8.5% Mar 2026 90 -36.6% Jun 2026 61 +43.8% Sept 2026 76 +20.4% - Per share
- ₹ per share
Sept 20267.24
Quarter ₹ per share Sept 2024 9.43 Dec 2024 7.08 Mar 2025 13.57 Jun 2025 4.07 Sept 2025 6.01 Dec 2025 6.48 Mar 2026 8.60 Jun 2026 5.85 Sept 2026 7.24
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 310 | 244 | 430 | 204 | 247 | 278 | 326 | 261 | 312 | |
| Revenue YoY | +18.2% | +1.4% | +34.8% | -5.5% | -20.4% | +13.9% | -24.2% | +27.7% | +26.4% |
| 10 | 15 | 9 | 14 | 13 | 10 | 16 | 13 | 10 | |
| 320 | 259 | 439 | 218 | 260 | 288 | 341 | 274 | 323 | |
| Cost structure | |||||||||
| 34 | 35 | 39 | 38 | 43 | 44 | 45 | 41 | 49 | |
| 187 | 160 | 254 | 160 | 175 | 195 | 223 | 191 | 221 | |
| Exceptional items and tax | |||||||||
| 133 | 99 | 185 | 57 | 86 | 90 | 118 | 82 | 102 | |
| 35 | 25 | 43 | 15 | 23 | 23 | 28 | 21 | 26 | |
| Profit | |||||||||
| 99 | 74 | 142 | 43 | 63 | 68 | 90 | 61 | 76 | |
| Net profit YoY | +16.8% | -0.6% | +46.0% | -26.9% | -36.3% | -8.5% | -36.6% | +43.8% | +20.4% |
| Per share | |||||||||
| 9.43 | 7.08 | 13.57 | 4.07 | 6.01 | 6.48 | 8.60 | 5.85 | 7.24 | |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.